Biomarker Commons

Cepmed Launches Online Personalized Medicine Portal

Biomarker Commons Newsbot — Thu, 23 Feb 2012 07:12:52 +0000

The Centre of Excellence in Personalized Medicine (Cepmed), announced recently that they have launched a web-based Personalized Medicine Portal for Canadians and joined DNA Direct by Medco's Genomic...

OGT Signs Licensing Deal for Colorectal Cancer Biomarkers

Biomarker Commons Newsbot — Wed, 22 Feb 2012 21:42:00 +0000

Oxford Gene Technology (OGT), provider of innovative clinical genetics and diagnostic solutions to advance molecular medicine, announced today that it has entered into an exclusive licensing...

Apceth and Indivumed to Develop Biomarker Platform for Targeted Cellular Therapies

Biomarker Commons Newsbot — Wed, 22 Feb 2012 20:46:38 +0000

apceth GmbH & Co. KG, located in Munich, Germany, and Indivumed GmbH, based in Hamburg, Germany, have entered into a partnership for the development of a predominantly tissue-based biomarker...

Dako Enters into an Additional CDx Collaboration with Amgen

Biomarker Commons Newsbot — Wed, 22 Feb 2012 14:45:55 +0000

Dako, a world leading independent cancer diagnostic supplier with 45 years of experience in pathology, announced today that it has entered into a new collaboration agreement with Amgen Inc. on the...

Fighting Breast Cancer: New EU-funded Biomarker Project Kicks Off

Biomarker Commons Newsbot — Tue, 21 Feb 2012 23:00:35 +0000

A new EU-funded biomarker project that aims to get breast cancer therapy more tailored to individual patients has just got under way. By ensuring that breast cancer therapy is specifically designed...

HistoRx Earns Patent on Quantitative Immunoassay Optimization

Biomarker Commons Newsbot — Tue, 21 Feb 2012 22:46:11 +0000

HistoRx, the leader in quantitative immunohistochemistry (IHC), advances its proprietary position in measurement of biomarkers in tissue through today's issuance of US Patent 8,121,365 protecting the...

Covance Scientists to Present at the Molecular Med Tri-Con

Walter Jessen — Mon, 20 Feb 2012 00:00:00 +0000

Scientists from Covance Discovery and Translational Services will be showcasing their company's R&D capabilities, talent and technologies in biomarkers, discovery services, genomics and...

Ingenuity Variant Analysis Enables Rapid Identification of Causal Variants From Human Resequencing Studies

Biomarker Commons Newsbot — Sat, 18 Feb 2012 04:11:00 +0000

Ingenuity Systems, a leading provider of information and analysis solutions for life science researchers, today announced the general availability of Ingenuity Variant Analysis, a web application...

SOMAscan Technology Presented at 2012 AAAS Meeting

Biomarker Commons Newsbot — Sat, 18 Feb 2012 04:03:32 +0000

“Prediction” is only part of what is needed to realize the promise of personalized medicine: It is perhaps more critical to detect the early onset of disease in real time, when it is most likely to...

FirstMark's Landmark Clinical Study Successfully Completed that Fulfills the Unmet Need to Access the Risk of Near Term MI

Biomarker Commons Newsbot — Sat, 18 Feb 2012 03:50:50 +0000

FirstMark today announced the completion of the clinical study for the multiple biomarker cardiovascular blood test PREvent. These clinical results demonstrate the extraordinary effectiveness of the...